Menu

Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib

Article |

hyperstorm0b 2mo ago
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib

Dear Editor,. Inferior outcomes have been observed with SARS-CoV-2 infection in patients with chronic myeloid neoplasms, emphasising the...

Comments (0)

Newest

No comments yet.